GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Scaled Net Operating Assets

Entheon Biomedical (XCNQ:ENBI) Scaled Net Operating Assets : -0.00 (As of Aug. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entheon Biomedical's operating assets for the quarter that ended in Aug. 2024 was C$0.02 Mil. Entheon Biomedical's operating liabilities for the quarter that ended in Aug. 2024 was C$0.02 Mil. Entheon Biomedical's Total Assets for the quarter that ended in May. 2024 was C$0.34 Mil. Therefore, Entheon Biomedical's scaled net operating assets (SNOA) for the quarter that ended in Aug. 2024 was -0.00.


Entheon Biomedical Scaled Net Operating Assets Historical Data

The historical data trend for Entheon Biomedical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Scaled Net Operating Assets Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Scaled Net Operating Assets
Get a 7-Day Free Trial 1.04 0.31 4.07 -0.01 -0.04

Entheon Biomedical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.07 -0.02 -0.02 -

Competitive Comparison of Entheon Biomedical's Scaled Net Operating Assets

For the Biotechnology subindustry, Entheon Biomedical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Scaled Net Operating Assets falls into.



Entheon Biomedical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entheon Biomedical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Nov. 2023 )
=(Operating Assets (A: Nov. 2023 )-Operating Liabilities (A: Nov. 2023 ))/Total Assets (A: Nov. 2022 )
=(0.056-0.085)/0.769
=-0.04

where

Operating Assets(A: Nov. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.401 - 0.345
=0.056

Operating Liabilities(A: Nov. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.085 - 0 - 0
=0.085

Entheon Biomedical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Aug. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Aug. 2024 )
=(Operating Assets (Q: Aug. 2024 )-Operating Liabilities (Q: Aug. 2024 ))/Total Assets (Q: May. 2024 )
=(0.02-0.02)/0.335
=-0.00

where

Operating Assets(Q: Aug. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.249 - 0.229
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Executives
Brian Jahns Senior Officer

Entheon Biomedical Headlines

No Headlines